Polycystic ovary syndrome (PCOS) is the most common cause of ovulatory disorders and female infertility. Signs and symptoms of PCOS may include anovulation or menstrual irregularities; ovarian cysts on ultrasound; hyperandrogenism including hirsutism, acne, and alopecia; insulin resistance; and obesity. Insulin resistance and secondary hyperinsulinemia appear to play a causative role in the development of PCOS. In addition, PCOS patients suffer from elevated oxidative stress and systemic inflammation. myo‐Inositol has been suggested as a first‐line therapy in the management of PCOS, and has been shown to be effective in mitigating the symptoms of this syndrome and its associated comorbidities.
Each scoop contains:
Inositol (myo‐inositol) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 g This product is non‐GMO.
Contains no: Gluten, soy, wheat, eggs, dairy, yeast, citrus, preservatives, artificial flavour or colour, added sweeteners, allergens, or starch.
DIRECTIONS FOR USE
Adults: Mix 1 scoop to 8 oz. (250 ml) of water or juice one to three times daily or as directed by your health‐care practitioner. Consult a health‐care practitioner for use beyond 6 weeks.
Inositol SAP can be used to restore normal ovarian function in women with oligomenorrhea and polycystic ovaries.
Inositol SAP may be helpful in restore ovulation, oocyte quality, and fertility, as well as to normalize menstrual irregularities.
Inositol SAP can be used to improve oxidative stress associated with PCOS.
Inositol SAP can be used to support management of PCOS’s hormonal and metabolic
conditions by promoting healthy glucose metabolism.
Inositol SAP can be used to improve acne, hirsutism, and hyperandrogenemia associated with PCOS.
myo‐Inositol is generally well tolerated. At therapeutic doses up to 4 g/d, no significant adverse events have been reported for the oral supplementation of myo‐inositol in studies for up to 6 months.
CAUTIONS AND WARNINGS
For adult use only. Consult a health‐care practitioner if you are pregnant or breast‐feeding. Discontinue use and consult a health‐care practitioner if you experience nausea, tiredness, headache, dizziness, abdominal pain, flatulence or soft stools.
PURITY, CLEANLINESS, AND STABILITY
All ingredients listed for all Inositol SAP lot numbers have been validated by an ISO 17025– accredited third‐party laboratory for identity, potency, and purity.